Alvarez, X Anton <br/><br/>
Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent cerebrolysin.  [electronic resource] 

 -  The international journal of neuropsychopharmacology  Aug 2009 
 - 867-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1469-5111 
<br/><br/><label>Standard No.: </label>10.1017/S1461145709990101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--blood<br/>Amino Acids--therapeutic use<br/>Biomarkers--blood<br/>Cognition--drug effects<br/>Disability Evaluation<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Down-Regulation<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Middle Aged<br/>Neuropsychological Tests<br/>Nootropic Agents--therapeutic use<br/>Placebo Effect<br/>Severity of Illness Index<br/>Spain<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--blood<br/>Up-Regulation